Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

539 ARTÍCULOS , VIENDO DEL 346 AL 360

Ageing as a risk factor for ALS/FTD

Niccoli T, Partridge L, Isaacs AM.

Hum Mol Genet. 2017 Oct 1;26(R2):R105-R113. doi: 10.1093/hmg/ddx247.

Traumatic brain injury may not increase the risk of Alzheimer disease

Weiner MW, Crane PK, Montine TJ, Bennett DA, Veitch DP.

Neurology. 2017 Oct 31;89(18):1923-1925. doi: 10.1212/WNL.0000000000004608. Epub 2017 Oct 4.

Low Prevalence and Clinical Effect of Vascular Risk Factors in Early-Onset Alzheimer's Disease

Chen Y, Sillaire AR, Dallongeville J, Skrobala E, Wallon D, Dubois B, Hannequin D, Pasquier F; Lille YOD study group.

J Alzheimers Dis. 2017;60(3):1045-1054. doi: 10.3233/JAD-170367.

Self-rated health and its association with mortality in older adults in China, India and Latin America-a 10/66 Dementia Research Group study

Falk H, Skoog I, Johansson L, Guerchet M, Mayston R, Hörder H, Prince M, Prina AM.

Age Ageing. 2017 Nov 1;46(6):932-939. doi: 10.1093/ageing/afx126.

Rheumatoid arthritis and risk for Alzheimer's disease: a systematic review and meta-analysis and a Mendelian Randomization study

Policicchio S, Ahmad AN, Powell JF, Proitsi P.

Sci Rep. 2017 Oct 9;7(1):12861. doi: 10.1038/s41598-017-13168-8.

Neuropsychological Measures that Predict Progression from Mild Cognitive Impairment to Alzheimer's type dementia in Older Adults: a Systematic Review and Meta-Analysis

Belleville S, Fouquet C, Hudon C, Zomahoun HTV, Croteau J; Consortium for the Early Identification of Alzheimer’s disease-Quebec.

Neuropsychol Rev. 2017 Dec;27(4):328-353. doi: 10.1007/s11065-017-9361-5. Epub 2017 Oct 10.

Dementia Risk in Posttraumatic Stress Disorder: the Relevance of Sleep-Related Abnormalities in Brain Structure, Amyloid, and Inflammation

Mohlenhoff BS, O'Donovan A, Weiner MW, Neylan TC.

Curr Psychiatry Rep. 2017 Oct 16;19(11):89. doi: 10.1007/s11920-017-0835-1.

Dextrometorphan-Paroxetine, But Not Dronabinol, Effective for Treatment-Resistant Aggression and Agitation in an Elderly Patient With Lewy Body Dementia

Wilhelm R, Ahl B, Anghelescu IG.

J Clin Psychopharmacol. 2017 Dec;37(6):745-747. doi: 10.1097/JCP.0000000000000805.

Prevalence and Correlates of Behavioral Disorders in Old Age Subjects with Cognitive Impairment: Results from the ReGAl Project

Boccardi V, Conestabile Della Staffa M, Baroni M, Ercolani S, Croce MF, Ruggiero C, Mecocci P; ReGAL study group.

J Alzheimers Dis. 2017;60(4):1275-1283. doi: 10.3233/JAD-170494.

Neuroepigenetic mechanisms in disease

Christopher MA, Kyle SM, Katz DJ.

Epigenetics Chromatin. 2017 Oct 16;10(1):47. doi: 10.1186/s13072-017-0150-4.

[Beyond Cognitive Impairment: Neuropsychiatric Symptoms in Neurodegenerative Dementias]

Ahunca Velásquez LF.

Rev Colomb Psiquiatr. 2017 Oct;46 Suppl 1:51-58. doi: 10.1016/j.rcp.2017.05.006. Epub 2017 Jun 27.

Using transcranial direct current stimulation to treat symptoms in mild cognitive impairment and Alzheimer's disease

Liu CS, Rau A, Gallagher D, Rajji TK, Lanctôt KL, Herrmann N.

Neurodegener Dis Manag. 2017 Oct;7(5):317-329. doi: 10.2217/nmt-2017-0021. Epub 2017 Oct 18.

Relationship between androgen deficiency and memory impairment in aging and Alzheimer’s disease

Jiménez-Rubio G, Herrera-Pérez JJ, Hernández-Hernández OT, Martínez-Mota L.

Actas Esp Psiquiatr. 2017 Sep;45(5):227-47. Epub 2017 Sep 1.

[Perspectives of the diagnosis of Alzheimer's disease using optic coherent tomography]

Bogolepova AN, Zhuravleva AN, Makhnovich EV.

Zh Nevrol Psikhiatr Im S S Korsakova. 2017;117(9):112-117. doi: 10.17116/jnevro201711791112-117.

Leisure time physical activity and dementia risk: a dose-response meta-analysis of prospective studies

Xu W, Wang HF, Wan Y, Tan CC, Yu JT, Tan L.

BMJ Open. 2017 Oct 22;7(10):e014706. doi: 10.1136/bmjopen-2016-014706.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias